Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer.
Autorzy:
Ryu HH; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea. Ahn SH; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea. Kim SO; Department of Clinical Epidemiology and Biostatistics, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Kim JE; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Kim JS; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea. Ahn JH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Jung KH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Kim SB; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Ko BS; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea. Lee JW; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea. Son BH; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea. Shin HJ; Department of Radiology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Kim HH; Department of Radiology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. GongGY; Department of Pathology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Kim HJ; Department of Breast Surgery, University of Ulsan, College of Medicine, Asan Medical Center, 88 Olympic ro 43 gil, song pa gu, Seoul, 138-736, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 May 18; Vol. 11 (1), pp. 10510. Date of Electronic Publication: 2021 May 18.
Publisher Correction: Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients.
Autorzy:
Gwark S; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Kim J; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. . Kwon NJ; Macrogen Inc, Seoul, Korea. Kim KY; Macrogen Inc, Seoul, Korea. Kim Y; Macrogen Inc, Seoul, Korea. Lee CH; Cytogen Inc, Seoul, Korea. Kim YH; Cytogen Inc, Seoul, Korea. Kim MS; Cytogen Inc, Seoul, Korea. Hong SW; Cytogen Inc, Seoul, Korea. Choi MY; Cytogen Inc, Seoul, Korea. Jeon BH; Cytogen Inc, Seoul, Korea. Chang S; Department of Biomedical Sciences, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Yu J; Department of Surgery, Division of Breast and Endocrine Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea. Park JY; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Lee HJ; Department of Pathology, University of Ulsan, College of Medicine, Asan Medical Center,, Seoul, Korea. Lee SB; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Chung IY; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Ko BS; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Kim HJ; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Lee JW; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Son BH; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Ahn JH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center,, Seoul, Korea. Jung KH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center,, Seoul, Korea. Kim SB; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center,, Seoul, Korea. GongGY; Department of Pathology, University of Ulsan, College of Medicine, Asan Medical Center,, Seoul, Korea. Ahn SH; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Mar 11; Vol. 11 (1), pp. 6148. Date of Electronic Publication: 2021 Mar 11.
Analysis of the serial circulating tumor cell count during neoadjuvant chemotherapy in breast cancer patients.
Autorzy:
Gwark S; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Kim J; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. . Kwon NJ; Macrogen Inc, Seoul, Korea. Kim KY; Macrogen Inc, Seoul, Korea. Kim Y; Macrogen Inc, Seoul, Korea. Lee CH; Cytogen Inc, Seoul, Korea. Kim YH; Cytogen Inc, Seoul, Korea. Kim MS; Cytogen Inc, Seoul, Korea. Hong SW; Cytogen Inc, Seoul, Korea. Choi MY; Cytogen Inc, Seoul, Korea. Jeon BH; Cytogen Inc, Seoul, Korea. Chang S; Department of Biomedical Sciences, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Yu J; Department of Surgery, Division of Breast and Endocrine Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea. Park JY; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Lee HJ; Department of Pathology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Lee SB; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Chung IY; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Ko BS; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Kim HJ; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Lee JW; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Son BH; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Ahn JH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Jung KH; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Kim SB; Department of Oncology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. GongGY; Department of Pathology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Ahn SH; Department of Surgery, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Oct 15; Vol. 10 (1), pp. 17466. Date of Electronic Publication: 2020 Oct 15.
Is asymptomatic surveillance beneficial after standard treatment? A 10-year survival analysis of recurrent BC patients by detection method of recurrence.
Autorzy:
Lee HS; Department of Surgery, Gyeongsang National University School of Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea. Kim J; Department of Surgery, Division of breast surgery, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. Chung IY; Department of Surgery, Division of breast surgery, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. Ko BS; Department of Surgery, Division of breast surgery, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. Kim HJ; Department of Surgery, Division of breast surgery, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. Lee JW; Department of Surgery, Division of breast surgery, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. Son BH; Department of Surgery, Division of breast surgery, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. Ahn JH; Department of Oncology, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. Jung KH; Department of Oncology, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. Kim SB; Department of Oncology, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. Lee HJ; Department of Pathology, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. GongGY; Department of Pathology, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. Ahn SH; Department of Surgery, Division of breast surgery, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea. Lee SB; Department of Surgery, Division of breast surgery, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Korea.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2020 Mar; Vol. 26 (3), pp. 556-559. Date of Electronic Publication: 2019 Sep 17.
Significance of EZH2 expression in canine mammary tumors.
Autorzy:
Choi HJ; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea. Jang S; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea. Ryu JE; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea. Lee HJ; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea. Lee HB; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea. Ahn WS; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea. Kim HJ; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea. Lee HJ; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea. Lee HJ; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea. GongGY; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea. Son WC; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea. .; Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, South Korea. .
Pokaż więcej
Źródło:
BMC veterinary research [BMC Vet Res] 2016 Aug 09; Vol. 12 (1), pp. 164. Date of Electronic Publication: 2016 Aug 09.
Enhanced biglycan gene expression in the adipose tissues of obese women and its association with obesity-related genes and metabolic parameters.
Autorzy:
Kim J; Department of Physiology, Cell Dysfunction Research Center, University of Ulsan College of Medicine, Seoul, Korea. Lee SK; Department of Physiology, Cell Dysfunction Research Center, University of Ulsan College of Medicine, Seoul, Korea. Shin JM; Department of Physiology, Cell Dysfunction Research Center, University of Ulsan College of Medicine, Seoul, Korea. Jeoun UW; Department of Physiology, Cell Dysfunction Research Center, University of Ulsan College of Medicine, Seoul, Korea. Jang YJ; Department of Physiology, Cell Dysfunction Research Center, University of Ulsan College of Medicine, Seoul, Korea. Park HS; Department of Family Medicine, University of Ulsan College of Medicine, Seoul, Korea. Kim JH; Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Seoul, Korea. GongGY; Department of Pathology, University of Ulsan College of Medicine, Seoul, Korea. Lee TJ; Department of Plastic Surgery, University of Ulsan College of Medicine, Seoul, Korea. Hong JP; Department of Plastic Surgery, University of Ulsan College of Medicine, Seoul, Korea. Lee YJ; Department of Family Medicine, Inha University, College of Medicine, Incheon, Korea. Heo YS; Department of General Surgery, Inha University, College of Medicine, Incheon, Korea.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Jul 28; Vol. 6, pp. 30609. Date of Electronic Publication: 2016 Jul 28.
A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer.
Autorzy:
Yoo C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Ahn JH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Kim JE; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Jung KH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. GongGY; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Son BH; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Ahn SH; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Ahn SD; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Kim HH; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Shin HJ; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Kim WK; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2015 Jul; Vol. 47 (3), pp. 406-15. Date of Electronic Publication: 2014 Nov 24.
Detection of internal mammary lymph node metastasis with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with stage III breast cancer.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
